Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A neoplasm with perivascular epithelioid cell differentiation often associated with tuberous sclerosis. It is characterized by a mixture of epithelioid cells, smooth muscle, vessels, and mature adipose tissue. The kidney is the most common site of involvement. Other sites of involvement include the liver, lung, lymph nodes, and retroperitoneum. The vast majority of cases follow a benign clinical course. However, cases of metastatic angiomyolipomas with sarcomatoid features have been described.
Biomarker and diagnostic research for angiomyolipoma has been reported in the published literature.
4 clinical trials registered, 1 recruiting. Interventions under study include drug therapy and medical devices. Pipeline includes 1 PHASE4, 1 PHASE2, 1 NA. Research is sponsored by a mix of industry and academic institutions.
266 publications have been identified in PubMed for angiomyolipoma. Research spans Case Report / Case Series (45%), Diagnostic / Biomarker (15%), and Review / Meta-Analysis (11%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 120 |
Data assembled from 3 of 12 sources · Last updated Sep 19, 2026, 6:43 AM UTC
Genetic and Rare Diseases Info Center
Testing and diagnosis research | 41 | 15% |
Research summaries | 29 | 11% |
Clinical study results | 25 | 9% |
Disease patterns and progression | 24 | 9% |
Laboratory research | 22 | 8% |
New treatment approaches | 3 | 1% |
Other research | 2 | 1% |
Bai Y (2026). [PMID: 40329155](https://pubmed.ncbi.nlm.nih.gov/40329155/). *J Imaging Inform Med*. [Basic Science / Preclinical]
Bani MA (2026). [PMID: 41093683](https://pubmed.ncbi.nlm.nih.gov/41093683/). *Ann Pathol*. [Case Report / Case Series]
Xiao Y (2026). [PMID: 42183966](https://pubmed.ncbi.nlm.nih.gov/42183966/). *Ann Surg Oncol*. [Diagnostic / Biomarker]
Soni JS (2026). [PMID: 41605552](https://pubmed.ncbi.nlm.nih.gov/41605552/). *BMJ Case Rep*. [Case Report / Case Series]
Tuller E (2026). [PMID: 41721485](https://pubmed.ncbi.nlm.nih.gov/41721485/). *Mol Genet Genomic Med*. [Case Report / Case Series]
Rout P (2026). [PMID: 36256751](https://pubmed.ncbi.nlm.nih.gov/36256751/). *Unknown Journal*. [Other]
Du Y (2026). [PMID: 42068102](https://pubmed.ncbi.nlm.nih.gov/42068102/). *Cancer Med*. [Basic Science / Preclinical]
Portilla A (2026). [PMID: 42181428](https://pubmed.ncbi.nlm.nih.gov/42181428/). *Cureus*. [Case Report / Case Series]
Bertrand J (2026). [PMID: 41722955](https://pubmed.ncbi.nlm.nih.gov/41722955/). *Kidney international*. [Epidemiology / Natural History]
Wang D (2026). [PMID: 41938446](https://pubmed.ncbi.nlm.nih.gov/41938446/). *Int J Surg Case Rep*. [Case Report / Case Series]